Effect of lipid viscosity and high-pressure homogenization on the physical stability of “Vitamin E” enriched emulsion

References

• Zingg J-M. Modulation of signal transduction by vitamin E. Mol Aspects of Med 2007;28:481–506
   PubMed Web of Science ®Google Scholar
• Shirode AB, Sylvester PW. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling. Biomed Pharmacother 2010;64:327–332
   PubMed Web of Science ®Google Scholar
• Bachawal SV, Wali VB, Sylvester PW. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells. BMC Cancer 2010;10:84
   PubMed Web of Science ®Google Scholar
• Wali VB, Sylvester PW. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells. Lipids 2007;42:1113–1123
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Tustian A, Kessler DR. Tocol emulsions for drug solubilization and parenteral delivery. Adv Drug Deliv Rev 2004;56:1243–1255
   PubMed Web of Science ®Google Scholar
• Yap SP, Yuen KH, Lim AB. Influence of route of administration on the absorption and disposition of alpha-, gamma- and delta-tocotrienols in rats. J Pharm Pharmacol 2003;55:53–58
   PubMed Web of Science ®Google Scholar
• Abuasal BS, Qosa H, Sylvester PW, Kaddoumi A. Comparison of the intestinal absorption and bioavailability of γ-tocotrienol and α-tocopherol: in vitro, in situ and in vivo studies. Biopharm Drug Dispos 2012;33:246–256
   PubMed Web of Science ®Google Scholar
• Abuasal B, Sylvester PW, Kaddoumi A. Intestinal absorption of γ-tocotrienol is mediated by niemann-pick c1-like 1: in situ rat intestinal perfusion studies. Drug Metab Dispos 2010;38:939–945
   PubMed Web of Science ®Google Scholar
• Li J, Nie S, Yang X, et al. Optimization of tocol emulsions for the intravenous delivery of clarithromycin. Int J Pharm 2008;356:282–290
   PubMed Web of Science ®Google Scholar
• Jumaa M, Müller BW. Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability. Eur J Pharm Biopharm 2002;54:207–212
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Hombreiro Perez M, et al. Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. Int J Pharm 1999;184:97–105
   PubMed Web of Science ®Google Scholar
• Alayoubi A, Nazzal M, Sylvester PW, Nazzal S. “Vitamin E” fortified parenteral lipid emulsions: Plackett–Burman screening of primary process and composition parameters. Drug Dev Ind Pharm 2013;39:363–373
   PubMed Web of Science ®Google Scholar
• Alayoubi A, Kanthala S, Satyanarayanajois SD, et al. Stability and in vitro antiproliferative activity of bioactive “Vitamin E” fortified parenteral lipid emulsions. Colloids Surf B 2013;103:23–30
   PubMed Web of Science ®Google Scholar
• Kato Y, Watanabe K, Nakakura M, et al. Blood clearance and tissue distribution of various formulations of alpha-tocopherol injection after intravenous administration. Chem Pharm Bull (Tokyo) 1993;41:599–604
   PubMed Web of Science ®Google Scholar
• Jumaa M, Müller BW. The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int J Pharm 1998;163:81–90
   Web of Science ®Google Scholar
• Desrumaux A, Marcand J. Formation of sunflower oil emulsions stabilized by whey proteins with high-pressure homogenization (up to 350 MPa): effect of pressure on emulsion characteristics. Int J Food Sci Technol 2002;37:263–269
   Web of Science ®Google Scholar
• Zhu S, Hong M, Liu C, Pei Y. Application of Box–Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation. Pharm Dev Technol 2009;14:642–649
   PubMed Web of Science ®Google Scholar
• Box GEP, Behnken DW. Some new three level designs for the study of quantitative variables. Technometrics 1960;2:455–475
   Google Scholar
• Yang C-R, Zhao X-L, Hu H-Y, et al. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers. Chem Pharm Bull (Tokyo) 2010;58:656–661
   PubMed Web of Science ®Google Scholar
• Jumaa M, Müller BW. Development of a novel parenteral formulation for tetrazepam using a lipid emulsion. Drug Dev Ind Pharm 2001;27:1115–1121
   PubMed Web of Science ®Google Scholar
• Alayoubi AY, Anderson JF, Satyanarayanajois SD, et al. Concurrent delivery of tocotrienols and simvastatin by lipid nanoemulsions potentiates their antitumor activity against human mammary adenocarcenoma cells. Eur J Pharm Sci 2013;48:385–392
   PubMedGoogle Scholar
• Constantinides P, Han J, Davis S. Advances in the Use of tocols as drug delivery vehicles. Pharm Res 2006;23:243–255
   PubMed Web of Science ®Google Scholar
• Kunieda H, Ohyama K-i. Three-phase behavior and HLB numbers of bile salts and lecithin in a water-oil system. J Colloid Interface Sci 1990;136:432–439
   Web of Science ®Google Scholar
• Hajri T, Férézou J, Lutton C. Effects of intravenous infusions of commercial fat emulsions (Intralipid 10 or 20%) on rat plasma lipoproteins: Phospholipids in excess are the main precursors of lipoprotein-X-like particles. Biochim Biophys Acta 1990;1047:121–130
   PubMed Web of Science ®Google Scholar
• Cheong JN, Tan CP, Man YBC, Misran M. α-Tocopherol nanodispersions: preparation, characterization and stability evaluation. J Food Eng 2008;89:204–209
   Web of Science ®Google Scholar
• Carrstensen H, Müller RH, Müller BW. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake. Clin Nutr 1992;11:289–297
   PubMed Web of Science ®Google Scholar
• Koster VS, Kuks PFM, Lange R, Talsma H. Particle size in parenteral fat emulsions, what are the true limitations? Int J Pharm 1996;134:235–238
   Web of Science ®Google Scholar